[IGOST guideline for pharmacotherapy of low back pain].
Strohmeier
Martin
M
Schmerzzentrum Bodensee-Oberschwaben, Ravensburg. dr.martin.strohmeier@igost.de
D000588:Amines / Q000627:therapeutic use; D000631:Aminopyridines / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D003937:Diagnosis, Differential; D000077206:Gabapentin; D006801:Humans; D017116:Low Back Pain / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology / Q000523:psychology; D008721:Methocarbamol / Q000627:therapeutic use; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009465:Neuromuscular Agents / Q000627:therapeutic use; D010024:Osteoporosis / Q000150:complications; D017410:Practice Guidelines as Topic; D014049:Tolperisone / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
D000588:Amines; D000631:Aminopyridines; D000700:Analgesics; D000701:Analgesics, Opioid; D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D003509:Cyclohexanecarboxylic Acids; D009125:Muscle Relaxants, Central; D009465:Neuromuscular Agents; D008721:Methocarbamol; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D014049:Tolperisone; C034161:flupirtine